- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 10-Q Quarterly report
- 10.1 Amendment NO.1 to Collaboration Agreement Dated July 28, 2003
- 10.2 Severance and Release Agreement with Amy P. Sing Dated August 7, 2003
- 10.3 Change of Control Agreement with Eric L. Dobmeier Dated March 29, 2002
- 10.4 Change of Control Agreement with Douglas E. Williams Dated September 30, 2003
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)
- 32.1 Certification of CEO Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of CFO Pursuant to 18 U.s.c. Section 1350
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the accompanying Quarterly Report on Form 10-Q of Seattle Genetics, Inc. (the “Company”) for the period ended September 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tim Carroll, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 12, 2003 | /s/ TIM J. CARROLL | |
Tim J. Carroll | ||
Chief Financial Officer |